Mattias Klintemar

Mattias Klintemar currently serves as Chief Investment Officer at Östersjöstiftelsen since April 2012, overseeing the management of the foundation's capital and direct investments in smaller companies. In addition to this role, Mattias holds several board positions, including Board Member at Velove and Biosergen, and is a member of the Investment Committee at Broviken Gruppen. Mattias has also been involved with Cell Impact AB as Chairman of the Nomination Committee and served on the board of Oatly AB, where responsibilities included Chairman of the Remuneration Committee and membership in the Audit Committee from 2021 to 2023. Other board affiliations include Palette Life Sciences, LightLab, and Moberg Pharma AB. Mattias's educational background includes a Bachelor of Business Administration in Accounting and Finance from Karlstad University and various graduation credentials.